Literature DB >> 26947428

Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.

Y-F He1,2, H-Q Luo1, W Wang1, J Chen1, Y-W Yao1, Y Yan2, S-S Wu2, X-X Hu2, L-H Ke2, J-Y Niu2, H-M Li2, C-S Ji1, B Hu1.   

Abstract

Neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) had been analysed in many kind of tumours, but its role of predict the oesophageal squamous cell carcinoma (ESCC) patients' prognosis was not reach a consensus. Relationship between NLR, PLR and ESCC located in the middle or lower segment was evaluated. 317 patients with ESCC who underwent attempted curative oesophagectomy were analysed in this study. 157 and 98 patients had elevated NLR and PLR respectively (NLR >3.3 and PLR >150). The median overall survival time (OS) and disease-free survival (DFS) was 34.1 and 19.2 months respectively. Multivariate analysis found PLR >150 (P = 0.018, HR 1.426, 95%CI 1.063-1.912) accompanied by male, lymphatic metastases, tumour size more than 3 cm, tumour located at middle segment and poor differentiation were associated with significantly worse DFS. Meanwhile, gender, lymphatic metastases, tumour location and differentiation along with PLR >150 (P = 0.003, HR 1.595, 95% CI 1.172-2.170) and NLR>3.3 (P = 0.039, HR 1.367, 95% CI 1.015-1.840) were all independent prognostic factors for OS. Preoperative NLR and PLR might be used as predictive factors in patients with ESCC. For DFS, elevated PLR compared to NLR may have an advantage to indicate poor prognosis.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990ESCCzzm321990; disease-free survival; neutrophil lymphocyte ratio; overall survival; platelet lymphocyte ratio

Mesh:

Year:  2016        PMID: 26947428     DOI: 10.1111/ecc.12445

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  11 in total

1.  Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis.

Authors:  Juhong Deng; Peng Zhang; Yue Sun; Ping Peng; Yu Huang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

Authors:  Lin Yang; Wenzhuo He; Pengfei Kong; Chang Jiang; Qiong Yang; Qiankun Xie; Liang Ping Xia
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

3.  Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis.

Authors:  Yu Huang; Yue Sun; Ping Peng; Sixian Zhu; Wei Sun; Peng Zhang
Journal:  Onco Targets Ther       Date:  2017-02-23       Impact factor: 4.147

4.  The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis.

Authors:  Yugui Sun; Lifei Zhang
Journal:  Cancer Manag Res       Date:  2018-11-22       Impact factor: 3.989

5.  Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis.

Authors:  Xiangwei Zhang; Yuanzhu Jiang; Yang Wang; Zhaoyang Wang; Linping Zhao; Xianbiao Xue; Shaowei Sang; Lin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 6.  Biomarkers for Evaluating the Inflammation Status in Patients with Cancer.

Authors:  Ali Guner; Hyoung-Il Kim
Journal:  J Gastric Cancer       Date:  2019-09-09       Impact factor: 3.720

7.  Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses.

Authors:  Lian Li; Jing Tian; Liwen Zhang; Luyang Liu; Chao Sheng; Yubei Huang; Hong Zheng; Fengju Song; Kexin Chen
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

8.  Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis.

Authors:  Binfeng Li; Fei Xiong; Shengzhong Yi; Sheng Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

9.  Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.

Authors:  Fu Ming-Sheng; Du Mei-Ling; Cai Xun-Quan; Hu Yuan-Xin; Zhang Wei-Jie; Pan Qin-Cong
Journal:  Can J Gastroenterol Hepatol       Date:  2022-01-04

10.  Neutrophil-Lymphocyte Ratio as an Initial Screening Biomarker for Differential Diagnosis of Cushing's Syndrome from Nonfunctional Adenoma in Patients with an Adrenal Mass.

Authors:  Wei Wang; Jianing Wang; Cheng Shen; Sainan Zhu; Ying Gao; Junqing Zhang
Journal:  Biomed Res Int       Date:  2021-02-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.